Intermittent Reprogramming: A Breath of Fresh Air for Lung Regeneration.
editorial · Level V
Where this comes from
- Record sourced from PubMed, PMID 29220663.
- Also identified by DOI 10.1016/j.stem.2017.11.015.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Recently in Stem Cell Reports, Guo et al. (2017) adopted an intermittent reprogramming strategy to generate "induced Progenitor-Like (iPL)" cells, which can maintain lineage commitment while undergoing controlled expansion. The iPLCs were successfully engrafted into a damaged airway, highlighting this significant advancement for regenerative medicine strategies in the lung.
Medical subject headings
- Cellular Reprogramming
- Regenerative Medicine